.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Harvard Business School
Daiichi Sankyo
Moodys
Argus Health
Healthtrust
McKinsey
Queensland Health
Chubb
Baxter

Generated: September 26, 2017

DrugPatentWatch Database Preview

CEFIZOX IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Cefizox In Plastic Container, and what generic Cefizox In Plastic Container alternatives are available?

Cefizox In Plastic Container is a drug marketed by Astellas and is included in one NDA.

The generic ingredient in CEFIZOX IN PLASTIC CONTAINER is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.

Summary for Tradename: CEFIZOX IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list28
Clinical Trials: see list468
Patent Applications: see list555
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFIZOX IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas
CEFIZOX IN PLASTIC CONTAINER
ceftizoxime sodium
INJECTABLE;INJECTION050589-003Apr 13, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
CEFIZOX IN PLASTIC CONTAINER
ceftizoxime sodium
INJECTABLE;INJECTION050589-004Apr 13, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Fuji
Healthtrust
Merck
US Army
Baxter
US Department of Justice
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot